Bristol-Myers Squibb signs an agreement for Bavarian Nordic’s PROSTVAC

Cellectis is preparing its IPO in the U.S

Roche spent $1B for the Leading Molecular Information Biotech company: Foundation Medicine

Nanobiotix on its way to change the paradigm in cancer therapy


After Merck’s Big Deal, Pfizer Collaborates with iTeos Therapeutics for Cancer Treatments

Munich: Why is it One of the Best Biotech Cluster in Europe ?

After AstraZeneca Turned Down Pfizer’s Bid, Merck Took the Opportunity

Onxeo confirms receipt of the $25M milestone payment from its US partner Spectrum

The First Patient Receives an Implant Pump System to manage Pleural Effusions

Novartis steps down completely from Vaccines’ Business

A Smart Collaboration to Diagnostic and Fight Cancer

New Peptide Technology Against Cancer bags 25 Million Euros